search
Back to results

Prospective Database for Acute Myeloblastic Leukemia

Primary Purpose

Leukemia, Myeloblastic, Acute

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Database
Sponsored by
King Faisal Specialist Hospital & Research Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional health services research trial for Leukemia, Myeloblastic, Acute focused on measuring AML

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with AML

Sites / Locations

    Outcomes

    Primary Outcome Measures

    safety and efficacy

    Secondary Outcome Measures

    Full Information

    First Posted
    October 1, 2007
    Last Updated
    December 11, 2011
    Sponsor
    King Faisal Specialist Hospital & Research Center
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00538278
    Brief Title
    Prospective Database for Acute Myeloblastic Leukemia
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2011
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 2007 (undefined)
    Primary Completion Date
    October 2020 (Anticipated)
    Study Completion Date
    October 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    King Faisal Specialist Hospital & Research Center

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Prospective Database for Acute Myeloblastic Leukemia

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Leukemia, Myeloblastic, Acute
    Keywords
    AML

    7. Study Design

    Primary Purpose
    Health Services Research
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    2000 (Anticipated)

    8. Arms, Groups, and Interventions

    Intervention Type
    Other
    Intervention Name(s)
    Database
    Other Intervention Name(s)
    Registry
    Intervention Description
    database
    Primary Outcome Measure Information:
    Title
    safety and efficacy
    Time Frame
    10 years

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with AML
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Naeem Chaudhri, MD
    Organizational Affiliation
    King Faisal Specialist Hospital & Research Centre
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Prospective Database for Acute Myeloblastic Leukemia

    We'll reach out to this number within 24 hrs